GSK
GlaxoSmithKline PLC ADRNYSEHEALTHCAREDRUG MANUFACTURERS - GENERAL
Key Statistics
Market Cap
$103.10B
P/E Ratio
13.45
EPS
$3.82
Beta
0.30
52W High
$60.65
52W Low
$34.17
50-Day MA
$53.74
200-Day MA
$49.00
Dividend Yield
3.51%
Profit Margin
17.80%
Forward P/E
10.96
PEG Ratio
9.87
About GlaxoSmithKline PLC ADR
GlaxoSmithKline plc is dedicated to the creation, discovery, development, manufacture and marketing of pharmaceuticals, vaccines, over-the-counter drugs and health-related consumer products in the UK, US and internationally. The company is headquartered in Brentford, the United Kingdom.
Fundamentals
| Revenue (TTM) | $32.78B |
| Gross Profit (TTM) | $23.89B |
| EBITDA | $11.43B |
| Operating Margin | 36.30% |
| Return on Equity | 40.90% |
| Return on Assets | 10.00% |
| Revenue/Share (TTM) | $16.25 |
| Book Value | $11.08 |
| Price-to-Book | 4.30 |
| Price-to-Sales (TTM) | 3.15 |
| EV/Revenue | 2.821 |
| EV/EBITDA | 9.17 |
| Quarterly Earnings Growth (YoY) | 8.40% |
| Quarterly Revenue Growth (YoY) | 1.50% |
| Shares Outstanding | $2.01B |
| Float | $3.89B |
| % Insiders | 0.06% |
| % Institutions | 18.74% |
Historical Volatility
HV 10-Day
20.41%
HV 20-Day
27.35%
HV 30-Day
26.22%
HV 60-Day
25.61%
HV Rank
42.1%
Volatility is currently contracting
Analyst Ratings
Consensus ($57.66 target)
1
Buy6
Hold1
SellMore HEALTHCARE Stocks
Data last updated: 5/25/2026